140 likes | 304 Views
Laboratory of Respiratory and Special Pathogens. History of the Laboratories. Laboratory of Pertussis. Laboratory of Respiratory and Special Pathogens. Laboratory of Methods Development and Quality Control. Product area specialists. Test development specialists. Structure of LRSP.
E N D
History of the Laboratories • Laboratory of Pertussis Laboratory of Respiratory and Special Pathogens Laboratory of Methods Development and Quality Control Product area specialists Test development specialists
LRSP Responsibilities • Pertussis vaccines • Anthrax vaccines • Plague vaccines
Pertussis Vaccines • Changes in formulation (Tdap, combination vaccines, removal of thimerosal) • Changes in manufacturing process • Ongoing monitoring
Anthrax Vaccines • Monitoring of licensed vaccine (AVA) • Assess new generation vaccines • Use of Animal Rule to demonstrate efficacy
Plague Vaccines • New generation plague vaccines • Use of Animal Rule to demonstrate efficacy
Structure of LRSP Pertussis Anthrax Pertussis Anthrax Plague
Regulatory Workload since 2000 • 365 INDs and amendments reviewed • 62 BLAs and BLA supplements reviewed • Taken a lead role within the Center on implementation of the Animal Rule
Research Program: Drusilla Burns • Bordetella pertussis • Structure/function studies of PT • Studies on the mechanism of secretion of PT • Bacillus anthracis • Role of surface proteins in virulence
Research Program: Tod Merkel • Bacillus anthracis • Identification of important virulence factors • Development of a mouse aerosol challenge model for inhalation anthrax • Bordetella pertussis • Characterization of critical virulence regulatory pathways
Research Program: Karen Meysick • Yersinia • Analysis of a novel type III secretion system of Y. pestis/Y. pseudotuberculosis • Characterization of the phospholipases of Y. pestis/Y. pseudotuberculosis • Development of biological assays to demonstrate correlates of protection for plague vaccines
Impact of Research on Regulatory Mission • Design release tests for DTaP vaccines • Helps manufacturers optimize production of PT • Conduct proof of concept studies that justify further development of anthrax vaccines and therapeutics • Identification of new candidate vaccine antigens for plague vaccines • Development of functional assays that can be used to define correlates of protection for plague vaccines
Relevance of Research to Regulation • State-of-the-art knowledge of the areas we regulate • Expertise to best evaluate tests to assess the safety, purity and potency of vaccines • Expertise to design and evaluate the efficacy studies for vaccines licensed under the Animal Rule • Credibility in the field • Problem solving approach